| ID | 10096 |
| Vaccine Name | Weisairuiji Biovac-A Mevac-A |
| Disease Name | Hepatitis A |
| Disease Classification | Hepatitic |
| Virus Name | Hepatitis A virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Inactivated |
| Vaccine Status | Approved |
| Manufacturer | Institute of Medical Biology, Chinese Academy of Medical Sciences |
| Year of Manufacturing | NA |
| Manufacturing Country | China |
| Age | NA |
| Dosage | P: 320 EU; Adults: 640 EU |
| Administration Route | Intramuscular |
| Adjuvant | Aluminum (aluminium hydroxide) |
| Target Strain | Lv-8 |
| Description | NA |
| Approving Organisation | China FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | 29661808 |
| Clinical Trial ID | NA |
| Reference Link | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ |
| Additional Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482852/
|